Page results
-
UCLH has recruited the first participant for a new UK based study for Parkinson’s Disease (PD). The ASPro-PD study is testing whether treatment with a drug called ambroxol is associated with an improvement in motor and non-motor function compared with placebo.
-
UCLH is the first NHS trust to pilot a personalised educational package for patients living with stroke.
-
Our staff have rated UCLH as the top trust in London to work at, and the third best in the country, during what has been another incredibly challenging year.
-
Information about our UCLH Charity, charity funds and associated charities.
-
Read more about the NHS Staff Survey 2024 - we’re the top acute trust to work at for third year running!
-
Our staff have rated UCLH as the top trust in England, improving on our ranking from last year when we were third best in England and top in London.
-
Christmas is an exciting time even if it will be a bit different for us all this year. We might be spending more time inside, making us less active than usual for this time of year. However, it is still a good time to relax and enjoy some Christmas treats.
-
King Charles III and Queen Camilla met patients and families living with cancer to hear their hopes and fears as they received care at UCLH in London today.
-
Holistic Needs Assessment (HNA): Information for people affected by cancer and blood conditions patient information leaflet
-
This page explains what patient-initiated follow-up (PIFU) involves after your treatment for endometrial (uterine or womb) cancer.
File results
-
FOI/2024/0400 - Gestational Diabetes Mellitus (GDM) screening and fetal outcomes
-
FOI/2024/0401 - Hospital treatments for abortion complications
-
FOI/2024/0402 - Various IT systems used at the Trust
-
FOI/2024/0403 - Risk Policy and corporate risk register
-
FOI/2024/0406 - Staff and patient discrimination complaints in 2021, 2022 and 2023
-
FOI/2024/0416 - Home dialysis treatment
-
FOI/2024/0420 - Commercialisation of NHS patient data
-
FOI/2024/0417 - Funding for point-of-care home blood monitoring devices for cancer patients
-
FOI/2024/0512 - Patient harm and the cost 2020-2023
-
FOI/2024/0415 - Biologic and targeted medications within dermatology medicine